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Objective: Placement in baboons of a distal femoral arteriovenous fistula increases shear stress through aortoiliac
polytetrafluoroethylene (PTFE) grafts and induces regression of a preformed neointima. Atrophy of the neointima might
be controlled by shear stress-induced genes, including the bone morphogenetic proteins (BMPs). We have investigated
the expression and function of BMPs 2, 4, and 5 in the graft neointima and in cultured baboon smooth muscle cells
(SMCs).
Methods: Baboons received bilateral aortoiliac PTFE grafts and 8 weeks later, a unilateral femoral arteriovenous fistula.
Results:Quantitative polymerase chain reaction showed that high shear stress increased BMP2, 4, and 5 messenger RNA
(mRNA) in graft intima between 1 and 7 days, while noggin (a BMP inhibitor) mRNA was decreased. BMP4 most
potently (60% inhibition) inhibited platelet-derived growth factor-stimulated SMC proliferation compared with BMP2
and BMP5 (31% and 26%, respectively). BMP4 also increased SMC death by 190%  10%. Noggin reversed the
antiproliferative and proapoptotic effects of BMP4. Finally, Western blotting confirmed BMP4 protein upregulation by
high shear stress at 4 days. BMP4 expression demonstrated by in situ hybridization was confined to endothelial cells.
Conclusions: Increased BMPs (particularly BMP4) coupled with decreased noggin may promote high shear stress-mediated
graft neointimal atrophy by inhibiting SMC proliferation and increasing SMC death. (J Vasc Surg 2006;43:150-8.)
Clinical Relevance: Pharmacologic therapy to prevent luminal stenosis or restenosis after vascular reconstruction is
directed at inhibiting intimal hyperplasia and smooth muscle cell growth. An alternative approach might be to induce
intimal atrophy after luminal narrowing has developed. This approach would be particularly useful for treating stenosis
in stented vessels or synthetic bypass grafts because intimal hyperplasia is the only mechanism for luminal narrowing.
Furthermore, it would permit the physician to treat the population of patients (about 30%) who actually develop a
problem with stenosis or restenosis. We have previously provided proof of principle that an established neointima can be
induced to atrophy in baboon polytetrafluoroethylene grafts, but not in normal artery, by simply switching from normal
to high blood flow and shear stress. In this study, we provide evidence that members of the bone morphogenetic protein
family may play a role in this neointimal atrophy.Exuberant growth of smooth muscle cells (SMCs) is a
characteristic of vascular diseases such as pulmonary hyper-
tension, in-stent restenosis, transplant atherosclerosis, and
vein graft failure.1 To date, the pharmacologic strategies
employed for these diseases have been aimed at preventing
neointimal hyperplasia, which is the primary mechanism of
stent and graft stenosis.2 However, since less than one third
of all stents and grafts fail because of intimal hyperplasia, an
alternative strategy is to develop therapies that reverse wall
thickening in only those patients with hyperplasia.
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150Proof of principle comes from two studies from our
laboratory that used a polytetrafluoroethylene (PTFE) aor-
toiliac graft model in baboons. In this model, bilateral,
unwrapped 60 m internodal distance PTFE grafts are
placed into the aortoiliac position. Unlike wrapped 30-m
internodal distance PTFE grafts used clinically, these grafts
uniformly heal by the ingrowth of capillaries through the
interstices of the PTFE graft. Complete endothelialization
is achieved by 2 weeks, and maximal, even neointimal
thickening is completed by 2 months.3-5 Atrophy of this
established neointima occurs when either blocking anti-
bodies to platelet-derived growth factor receptors
(PDGF)- and - are administered6 or when blood flow
and shear stress are increased by the creation of a distal
femoral arteriovenous fistula.5 The loss of intima is associ-
ated with decreased proliferation and increased apoptosis of
neointimal SMCs as well as loss of matrix.7-9 These results
are consistent with the association of increased blood flow
and shear stress with decreased intimal thickening in ath-
erosclerotic arteries and vein grafts and injured vessels.5
Of greater interest with regards to the regression of an
established neointima are several similarities of this PTFE
model to arteries after stent-angioplasty that undergo spon-
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grafts and stented arteries are not distensible, have a pro-
teoglycan rich region near the endothelium with less near
the inflammatory foreign material,9,12 and exhibit in-
creased apoptosis near the foreign material and increased
cell proliferation near the endothelium.8,12,13 In the PTFE
graft neointima undergoing regression in response to high
flow, there is a loss of proteoglycans and a relative increase
in collagen,9 similar to what is observed in stented arteries
undergoing spontaneous intimal regression at late
times.14,15 The PTFE graft thus models interesting aspects
of clinically observed pathology.
In this report, we describe our investigation of changes
in graft neointimal gene expression in response to high
shear stress. Observing that several members of the bone
morphogenetic protein (BMP) family were upregulated by
elevated shear stress, we focused our investigation on the
expression of several members of the BMP family and
noggin (a BMP antagonist) in the graft neointima and their
effects on cultured baboon SMCs.
METHODS
Complete methods and results, including microarray
analysis, are presented as an online Appendix.
Baboon model. Male baboons received bilateral aor-
toiliac PTFE bypass grafts. After 2 months, unilateral fem-
oral arteriovenous fistulas were constructed as described7,8
to increase blood flow and shear stress in the upstream
ipsilateral graft and iliac artery. Animals were euthanized at
days 1, 4, and 7 (5 each day, 15 total) by using intravenous
sodium pentobarbital (160 mg/kg). All procedures were
performed in accordance with the guidelines of the Univer-
sity of Washington Institutional Animal Care and Use
Committee.
Taqman reverse transcriptase polymerase chain
reaction. Total RNA for microarray and Taqman analysis
was prepared from the frozen neointima of the graft by
using Solution D/phenol/chloroform/isopropanol.16
RNA quantity and quality was characterized spectrophoto-
metrically by using OD 260/280 (1.96  0.06), by aga-
rose gel electrophoresis, and analysis of the sample on the
Agilent 2100 Bioanalyzer (Palo Alto, Calif). Five micro-
grams of graft intima total RNA from individual animals
was combined to form six pools for each time point and
blood flow combination; average yield of total RNA from
individual grafts was 11  6 g. The rationale for pooling
stems from the fact that these animals were used for mi-
croarray analysis of the effects of high blood flow on intimal
gene expression (see online Appendix). We did not have
enough total RNA from some individual animals, so form-
ing pools of the intimal samples taken at 1, 4, and 7 days
allowed us to screen about 32,000 genes with four repli-
cates.
Taqman reverse transcriptase-polymerase chain reaction
(RT-PCR) of BMP4 and noggin was performed by using the
RNA pools with the GeneAmp 5700 sequence detection
system (Applied Biosystems, Foster City, Calif). Primers and
probes were designed by using Primer Express 2.0 (AppliedBiosystems) to crossmultiple exons of BMP4 (forward primer
5=-ACCACGAAGAACATCTGGAGAAC-3=, reverse primer
5=-TGCTGAGGTTAAAGAGGAAACGA-3=, probe 5=-6[6-
carboxy-fluorescein]-TCCCAGGGACCAGTGAAAACTC-
TGCTT-[6-carboxy-tetramethlyl-rhodamine]- 3’), and nog-
gin (forward 5=-CCTGGTGGACCTCATCGAA-3=, reverse
5=-CAGCGTCTCGTTCAGATCCTT-3=, probe 5=-6[6-
carboxy-fluorescein]-ACCCAGACCCTATCTTTGAC-
CCCAAG-GA-[6-carboxy-tetramethlylrhodamine]- 3’), and
were synthesized by Applied Biosystems. The cycling condi-
tions were 2 minutes at 50°C, 10 minutes at 95°C, followed
by 40 cycles of 15 seconds at 95°C, and 1 minute at 60° for
combined annealing and extension.
Standard curves of dilutions of plasmids containing
BMP4 or noggin (I.M.A.G.E. clone 4399276 and
4727725, Research Genetics) were used to calculate the
messenger RNA (mRNA) copy number. Ribosomal RNA
control reagents (Applied Biosystems) were used as an
internal control, and the calculated amount of mRNA was
normalized by the amount of 18S present.
In a separate series of assays on the same RNA pools,
quantitation of BMPs 2, 4, and 5 was done using Applied
Biosystems predesigned Taqman primer and probe sets
(PDARs, see ABI P/N 4333458_a.pdf for the complete
protocol). We used StratageneUniversal Target total RNA.
We synthesized first strand complimentary DNA (cDNA)
by using random primers and the Applied Biosystems High
Capacity cDNA Archive Kit (P/N 4322171). Two exper-
iments with duplicate PCR reactions, which used 10-ng
equivalents of total RNA, were run on the ABI 7900
machine with the standard cycling protocol and increasing
the number of cycles to 44. -Glucuronidase (GUSB) and
TATA binding protein (TBP) were used as the internal
reference in all of the samples and calibrator. The delta-
delta Ct method was used to calculate ratios of each gene in
each sample against the calibrator RNA (see ABI P/N
4333458_a.pdf for the complete protocol). Both refer-
ences gave similar results, and we present the combined
average of the GUSB data.
Morphometry and immunohistochemistry.
Formalin-fixed, paraffin-embedded, sections of tissue ob-
tained from the middle of the PTFE graft were stained with
hematoxylin and eosin, and the neointimal area was deter-
mined by computer-assisted morphometry. Neointimal cell
proliferation and death indices were determined by anti-bro-
modeoxyuridine staining and terminal deoxynucleotidyl
transferase-mediated dUTP nick-end labeling of fragmented
DNA (TUNEL), as previously described.8 For immunohisto-
chemical staining, tissue sections were blocked for 1 hour at
37°C with 20% horse serum and 5% albumin, and then incu-
bated overnight at 4°C with goat antibodies to human
BMPR-IA, BMPR-IB, and BMPR–II (Santa Cruz Biotech-
nology Inc, Santa Cruz, Calif). Sections were then incubated
with horse biotinylated secondary antibodies (Vector Labs,
Burlingame, Calif) at room temperature for 30 minutes, fol-
lowed by avidin-biotin-peroxidase (Elite ABC kit; Vector
Labs). Normal goat immunoglobulin G (Santa Cruz) was
used as a negative control.
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exposed to 4 days of high or normal shear stress were
pulverized and extracted with 20 mM Tris, 100 mM so-
dium chloride, 1 mM EDTA, 0.5% IGEPAL CA-630
(Sigma, St. Louis, Mo), 0.1 mM AEBSF (Calbiochem, San
Diego, Calif), pH 8.0. After centrifugation, the concentra-
tion of protein in the supernatant was determined (BCA,
Pierce, Rockford, Ill), and 30-g samples of protein were
subjected to 10% sodium dodecyl sulfate polyacrylamide
gel electrophoresis followed by Western blotting. Blots for
BMP4 were blocked with 20% normal sheep serum plus 5%
albumin for 1 hour at 37°C. Blots were then incubated
overnight at 4°C with monoclonal anti-BMP4 at 0.5
g/mL (R &D Systems, Minneapolis, Minn). Protein was
visualized by enhanced chemiluminescence (ECL, Amer-
sham Pharmacia, Piscataway, NJ).
In situ hybridization. The BMP4 cDNA clone used
for RT-PCR was linearized, transcribed into antisense and
sense riboprobes, and labeled with 35S-UTP (Riboprobe
Combination System-SP6/T7 RNA Polymerase, Pro-
mega, Madison, Wisc) for in situ hybridization on forma-
lin-fixed sections as described.17
Cell proliferation. Baboon aortic and graft neointi-
mal SMCs grown from explants were cultured in Dulbec-
co’s Modified Eagle Medium with 10% or 20% fetal bovine
serum (aortic and neointimal SMCs, respectively). After
wiping away endothelial cells, the neointima separates easily
and cleanly from the PTFE graft material by dissection. The
neointimal SMCs were obtained from the neointimal tissue
by outgrowth from about 1-mm2 explants in which 99%
of neointimal cells are SMCs (by -SM actin immuno-
histochemical staining; 0.05% macrophages by
HAM56).8,18 Essentially 100% of the cultured cells are also
-SM actin positive.19 Subconfluent SMCs were changed
to serum-free medium for 72 hours before the addition of
recombinant BMP2, BMP4, BMP5, noggin, PDGF-BB20
(all from R & D Systems), or serum. After 10 hours,
3H-thymidine (1 Ci/mL) was added. After 28 hours,
DNA was harvested and radioactivity was determined as
described.21
Cell death. Cell death was determined by detection of
cytoplasmic histone/DNA complexes (mono- and oligo-
nucleosomes) by enzyme-linked immunoabsorbent assay
(Cell Death Detection kit, Roche Diagnostics, Indianapo-
lis, Ind) following the manufacturer’s instructions.
Statistical analysis. Values reported are the mean 
SEM. Each in vitro experiment was repeated at least three
times. Statistical significance of DNA synthesis and cell
death assays was determined by using multiple analyses of
variance and the Student’s t test (SPSS Inc, Chicago, Ill).
RESULTS
By 2 months, PTFE grafts develop a thick neointima.5 We
confirmed and extended previous observations8 that the
switch to high flow causes a significant decrease in intimal
cross-sectional area by showing that high shear stress increased
SMC death and decreased SMC proliferation as early as one
day after the switch to high flow (Table I).BMP and noggin expression. Because microarray re-
sults suggested thatmembers of the BMP family are regulated
by high blood flow*we performed Taqman RT-PCR analysis
to determine message levels for BMP2, 4, and 5. We found
that BMP2 message was increased at days 1 and 7, BMP4
*See supplemental data for a complete description of the microarray
experiment. The complete set of array data is at http://www.cs.
washington.edu/homes/ruzzo/papers/ATVB/Flow (user: Hsieh;
Table I. Hemodynamic, morphologic, and biochemical
changes in polytetrafluoroethylene graft intima in
response to high blood flow
Day 1 Day 4 Day 7
Blood velocity
(cm/sec)
Normal 18  3 21  2 24  5
High 85  9 93  11 82  6
H/N 4.82  0.83* 4.41  1.18* 3.77  1.02*
Shear stress
(dyne/cm2)
Normal 14  2 18  2 16  3
High 66  9 74  8 64  9
H/N 4.88  0.74* 4.01  1.30* 3.98  1.10*
Intimal area
(mm2)
Normal 3.25  0.28 3.98  0.43 3.17  0.19
High 2.67  0.33 2.96  0.23 2.19  0.13
H/N 0.82  0.11 0.76  0.15† 0.69  0.08†
BrdU index
(% positive)
Normal 5.69  1.05 6.22  0.79 5.45  0.37
High 4.15  0.64 4.67  0.51 4.52  0.93
H/N 0.73  0.12† 0.75  0.23† 0.83  0.17
TUNEL index
(% positive)
Normal 2.15  0.84 1.96  0.48 2.39  0.71
High 3.66  1.23 6.41  0.58 9.18  2.01
H/N 1.70  0.41† 3.27  1.22* 3.84  0.51*
H/N, High to normal ratio; BrdU, bromodeoxyuridine; TUNEL, trans-
ferase-mediated dUTP nick-end labeling of fragmented DNA.
Details of the protocols for the hemodynamic and morphologic measure-
ments and the BrdU and TUNEL assays are described in supplemental
methods. Data are the mean  SEM (n  5) of H/N values at 1, 4, and 7
days after the switch to high flow.
*P  .01.
†P  .05.
Table II. Taqman analysis of changes in expression of
bone morphogenetic proteins in the polytetrafluoro-
ethylene graft neointima under high shear stress
Expression (H/N)
Gene Day 1 Day 4 Day 7
BMP2 1.60 1.10 1.54
BMP4 1.15 1.60 1.73
BMP5 1.00 0.72 1.32
Noggin 0.44 0.74 0.82
BMP, Bone morphogenetic protein.
Values are the mean values of the ratios of high to normal (H/N) shear stress
samples of assays performed in triplicate on two to five separate occasions.password: ilikethispaper).
seru
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decreased on day 4 and increased on day 7 (Table II). In
contrast,message levels of noggin, an inhibitor of BMPs, were
decreased by high blood flow (Table II).
BMPs inhibit SMC proliferation and increase
SMC death. Because BMP2, 4, and 5 were regulated by
high blood flow, we investigated the relative activity of
each in cultured SMCs. Although each of these BMPs
Fig 1. Effect of bone morphogenetic proteins (BMP
dependant effect of BMP2, 4 (B4) and 5 on DNA synth
growth factor-BB (P-BB). Data are presented as the pe
line) and triangles (dotted line) represent BMP2, BMP
B, Dose-dependant effect of BMP4 on DNA synthesis
with 10 ng/mL PDGF-BB. Data are presented as the p
noggin (Ng) of the inhibitory effect of 30 ng/mL BM
(10 ng/mL). Data are presented as the percent of theshowed a similar inhibitory trend toward PDGF-BB–mediated DNA synthesis by baboon aortic SMCs, only
BMP4 had a strong, statistically significant effect (about
60% inhibition) (Fig 1, A ). The BMPs alone had no
effect on DNA synthesis (data not presented). BMP4 was
the most potent, and no additive effects resulted when
BMPs were added in combinations of two (each at 30
ng/mL; data not presented); therefore, the effects of
BMP4 were further explored by using baboon PTFE
smooth muscle cell (SMC) proliferation. A, Dose-
n aortic SMCs treated with 10 ng/mL platelet-derived
t of PDGF-BB. Diamonds (dashed line), squares (solid
d BMP5, respectively. *P .05, **P .01, ‡P .06.
olytetrafluoroethylene graft neointimal SMCs treated
t of PDGF-BB. **P .01.C, Reversal by 300 ng/mL
n the stimulation of SMC proliferation by PDGF-BB
m-free medium control. **P  .01.) on
esis i
rcen
4, an
by p
ercen
P4 ograft neointimal SMCs.
ar str
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attenuated intimal SMC proliferation in response to
PDGF-BB (Fig 1, B). In both cases the optimal concentra-
tion of BMP4was 30 ng/mL, with higher doses having less
effect in a biphasic manner similar to that observed with
BMP2.22 BMP4 also inhibited proliferation of neointimal
SMCs mediated by basic fibroblast growth factor (10 ng/
mL) and by 1% fetal bovine serum (data not shown).
Noggin alone at 300 ng/mL had no effect on intimal SMC
proliferation, but reversed the antiproliferative effect of 30
Fig 2. Effects of bone morphogenetic protein 4 (B4) o
by enzyme-linked immunoabsorbent assay. A, Effect
10 ng/mL platelet-derived growth factor BB (P-BB) or
of SMC death induced by BMP4 (30 ng/mL). Data are p
time point.
Fig 3. Expression of bone morphogenetic protein 4
Western blot analysis of intimal extracts of grafts expose
panel) of the combined results from three animals is pr
human (rh) BMP4 was used as a positive control. Arrow
non-immune mouse immunoglobulin G. HSS, High sheng/mL BMP4 by 76%  6% (Fig 1, C). Similar results withnoggin were obtained using aortic SMCs (data not pre-
sented).
BMP4 alone increased neointimal SMC death by two-
fold and had more of an effect in the presence of 10ng/mL
PDGF-BB or 0.5% serum (Fig 2, A). Of interest, this effect
was only seen after 2 days of treatment (Fig 2, B). Noggin
at 300 ng/mL had no effect on intimal SMC death but
reversed the death-inducing effect of BMP4 (30 ng/mL)
by 65%  5% (P  .01, n  3).
BMP4 and BMP receptors in vivo. Levels of BMP4
intimal smooth muscle cell (SMC) death as determined
ng/mL BMP4 on SMC death after treatment with
serum for 2 days. *P  .05; **P  .01. B, Time course
ted as percent of the serum-free medium control at each
e polytetrafluoroethylene neointima as determined by
igh flow for 4 days (left panel.) A graphic display (right
ed as the percent of normal flow values. Recombinant
indicate nonspecific bands as determined by results with
ess; NSS, normal shear stress; *P  .01.n neo
of 30
0.5%
resenin th
d to h
esent
headsprotein in neointimal extracts as determined by Western
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(Fig 3), which is consistent with the change in mRNA
(Table II). BMP4 mRNA was observed only in endothelial
cells by in situ hybridization (Fig 4). Because BMP4 binds
to BMPR-IA, -IB, and -II,23,24 we surveyed neointimal
expression of these receptors by using immunohistochem-
istry. Endothelial cells and SMCs in the superficial neoin-
tima were positive for BMPR-IA, but SMCs of the deep
neointima demonstrated the strongest staining for BMPR-
IA, -IB, and –II (Fig 5). Immunostaining for BMPR-IA,
-IB, and -II was not appreciably affected by increased flow
(data not shown).
DISCUSSION
In this report, we provide evidence that increased BMP
Fig 4. In situ hybridization for bone morphogenetic protein
(BMP4) in the polytetrafluoroethylene (PTFE) intima of grafts
exposed to high shear stress for 4 days. A, Antisense sequence of
BMP4. The black-silver grains indicate a positive signal. B, Sense
sequence of BMP4 for negative control.Arrows indicate the endo-
thelial cells. L, Lumen of PTFE. Magnification 1000.expression, including BMP4, may underlie the neointimalatrophy induced by elevated SS in baboon PTFE grafts.
Both SMC proliferation and death are altered by day 1 and
message levels of BMP2 are increased by day 1. Although
BMP4 RNA is not increased on day 1, message levels of the
BMP4 inhibitor, noggin,25 are decreased by day 1. Loss of
the inhibitor raises the possibility that BMP activity is
increased before BMP4 protein changes by day 4. BMP2
and BMP7 have been shown to inhibit SMC or mesangial
cell proliferation in vitro (and in vivo for BMP2) mediated
by PDGF-BB and 1% serum.22,26-31 Although BMP2, 4,
and 7 can inhibit SMC growth, this is not universally
observed. Takeda et al27 found that BMPs 2 and 7, but not
4 or 6, inhibited human SMC entry into S phase in response
to 1% serum plus PDGF. Nakaoka et al22 found that BMP2,
but not BMP7, inhibited entry into S phase by rat SMCs in
response to 10% serum, possibly owing to differential bind-
ing to BMP receptors.32 These BMPs can have other
differential effects. For example, BMP2 inhibits, while
BMP4 stimulates, expression of the SMC markers -SM22
and -smooth muscle actin.32,33 The observation that
BMP4 had similar effects on aortic and graft SMCs is
important, because graft SMCs are primarily derived from
pericytes and Yang et al34 found opposite effects of BMP4
on the growth of SMCs from different vascular beds.
BMPs are members of the transforming growth factor
(TGF)- superfamily. They regulate cell proliferation, dif-
ferentiation, migration, and apoptosis during embryonic
development.25,35-37 BMPs are dimers that bind two type I
(BMPRIA and -IB, or ActR-I) and one type II (BMPR-II
or ActR-IIB) serine/threonine kinase receptors.37 Noggin
is one of a number of secreted BMP antagonists that acts by
binding BMPs and preventing their interaction with BMP
receptors.25,38 Binding of BMP to the BMPRs leads to
phosphorylation of the type I receptor by the type II
receptor. In turn the type I receptor phosphorylates Smads
(intracellular mediators), which then move to the nucleus
and act in concert with other molecules to regulate tran-
scription.37 Evidence has also accumulated indicating that
BMPs can activate members of the mitogen-activated pro-
tein kinase (MAPK) pathways. There are reports of both
cooperative and antagonistic interactions between the p38
and Smad pathways.39-41
BMPs probably play an important role in vascular dis-
ease. Genetic defects of BMP receptors (BMPRs) have been
linked to the pathogenesis of pulmonary artery hypertrophy
and hypertension in humans.42,43. In addition, BMP2 and
BMP4 have been detected in atherosclerotic plaques.44
Although hemodynamic forces, especially shear stress, have
been shown to regulate gene expression in arteries and
vascular implants45,46 via specific 5= shear response ele-
ments,47-49 there are no known shear response elements in
the 5= promoter region of BMP2 or BMP4. The delayed
induction of BMP4 in vivo suggests that intermediate
factors control BMP4 expression. Sorescu et al50 reported
that increasing levels of laminar shear decreased BMP4
expression in endothelial cells in 24 hours. In addition,
laminar shear stress increased Smad6 and -7 transcription in
3 hours.51 How these in vitro data relate to the in vivo
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BMP4, the 5= upstream region of noggin contains a con-
sensus sequence for AP-1 that is required for shear stress-
mediated downregulation of vascular cell adhesion mole-
cule-1 in endothelial cells.52,53 Thus, AP-1 may mediate
the downregulation of noggin observed after the switch to
high shear stress.
The mechanisms by which BMP4 inhibits SMC prolif-
eration and causes cell death are not known. BMP2 in-
creases levels of the cell cycle inhibitor, p21, and antisense-
Fig 5. Localization of bone morphogenetic protein
BMPR-IA (A), -IB (B), and –II (C) in polytetrafluoroeth
Location of magnified areas (1000) are indicated by the
of PTFE. Magnification 200.mediated reduction of p21 blocks the inhibitory effect ofBMP2 on aortic SMC proliferation.29 Wong et al29 found
that 1 day of treatment with BMP2 did not cause SMC
death, but Zhang et al54 observed substantial apoptosis in
pulmonary SMCs after two days of treatment with either
BMP2 or BMP7. These investigators found that BMP2
increased Smad1 phosphorylation by 2 hours and de-
creased levels of the antiapoptotic protein, Bcl2, by 24
hours.
In contrast to Zhang et al, Dorai et al26 reported that
BMP7 inhibited aortic SMC death (in data not shown),
tors (BMPRs). Immunostaining (orange/brown) of
e (PTFE) grafts exposed to 4 days of normal shear stress.
s. L, Lumen of graft;NI, neointima of graft;MA,matrixrecep
ylen
boxewhich they ascribed to the loss of p53. We also found that
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of BMP4 in the baboon graft intimal SMCs. This suggests
a dependence of the process on the synthesis of upstream
proapoptotic mediators or slow turnover of antiapoptotic
factors. Alternatively, BMP4 may cause SMCs to become
dependent on exogenous survival factors.55 In other in
vitro cell systems, death caused by BMP4 and BMP2 is
mediated by Smad1/5 and p38 MAPK56,57 induction of
the transcriptional regulator Msx257,58 and repression of
the anti-apoptotic protein Bcl-Xs.57 Of particular interest is
the observation that specific cell-cell and cell matrix inter-
actions are required for the effect of BMP4 and Msx2
expression on cell death.58 In this regard, SMC death is
only observed in the deep neointima, which has more (and
more tightly organized) collagen I and biglycan with less
glycosaminoglycans compared with the subendothelial ma-
trix.9 This difference in matrix may alter both the effect and
distribution of BMP4. Heparan sulfate proteoglycans such
as the glypicans may regulate the distribution and activity of
BMP4 and noggin.59,60
CONCLUSION
The counter-regulation of BMP4 and noggin coupled
with the growth inhibitory and proapoptotic effects of
BMP4 in vitro support a role for BMP4 and noggin in shear
stress-mediated neointimal atrophy. These data plus the
data linking BMPR mutations to pulmonary hyperten-
sion42,43 and showing the increased presence of BMPs in
atherosclerotic lesions44 suggest that BMPs play a signifi-
cant role in vascular pathology. Understanding the func-
tion and regulation of BMP ligands, BMPRs, antagonists
(eg, noggin) and, in particular, the signalingmechanisms of
BMP4 in controlling SMCproliferation and deathmay lead
to therapeutic tools for the prevention or reversal of neo-
intimal hyperplasia.
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